Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company InflaRx GmbH
DescriptionBi-specific mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard Indication Inflammation (unspecified)
Indication DetailsTreat sub-acute and chronic inflammatory diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today